Determination of Vascular Endothelial Growth Factor-B Concentrations in Aqueous Humor and Plasma of Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients Before and After Anti-VEGF Therapy.
Huiying ZhouXinyu ZhaoShuran WangYou-Xin ChenPublished in: Ophthalmology and therapy (2022)
Overexpression of VEGF-B locally and systemically in patients with nAMD and PCV indicated that elevated VEGF-B concentrations were relevant to the disease processes. Ranibizumab did not influence the levels of VEGF-B in the real world. CRT might help to distinguish PCV from nAMD.
Keyphrases
- vascular endothelial growth factor
- age related macular degeneration
- endothelial cells
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- cell proliferation
- patient reported outcomes
- bone marrow
- mass spectrometry
- high resolution
- smoking cessation
- mesenchymal stem cells
- atrial fibrillation
- optical coherence tomography
- replacement therapy